Název projektu:
Low Viscosity Biopolymer for Food Applications (11 US 87GA 3LZK)
Popis:
A large US company is looking for novel, edible biopolymers that produce low viscosity aqueous dispersions/solutions at high concentrations, and are suitable for commercial scale use.
They are interested in licensing, product acquisition, joint development, supplier agreement.
Biopolymers are commonly used raw materials in both food and non-food applications. In food products, they may function as fillers or bulking agents, texture or viscosity modifiers, energy sources and as stabilizers. In more specialized applications, biopolymers can be used carriers and encapsulants for flavor and fragrance materials.
Biopolymers may be derived from botanical, marine, microbial, and animal sources. Common and commercially available examples include starches from corn or tapioca, carrageenan from seaweek, xanthan gum from bacteria, and gelatin from animal skin or bones. Physical, chemical, and enzymatic methods may be used to further modify polymers, yielding materials with enhanced properties.
Most biopolymers have high molecular weights that typically produce high viscosity through physical, chemical, or enzymatic means way result in the loss of desirable properties and/or in the formation of low molecular weight oligomers that may adversely affect the properties of the finished product.
The company is interested in identifying novel eligible biopolymers that create highly concentrated aqueous dispersions with low viscosity. These materials will preferably also possess desirable functional properties, such as the ability to serve as an emulsifying agent, to form films or minimize stickiness. Preferred biopolymers will already be produced at pilot scale of better and will have roughly the same cost-in-use as market products.
Anticipated approaches include, but are not limited to, the following:
- Enzymatic, chemical, and/or physical modification of naturally occurring or commercially available polymers or other feedstock
- Isolation or synthesis of novel biopolymers via fermentation or other biochemical methods.
The following approaches are not of interest:
- Approaches that result in unacceptable levels of hazardous chemicals as defined by FDA 21 CFR Part 184
- Early stage approaches or materials that cannot be scaled to industrial levels.
Technical Specifications / Specific technical requirements:
The successful biopolymer will:
- Be approved for use in food products or have potential to be approved for such use
- Disperse readily in water
- Produce low viscosity aqueous dispersions: ‹ 40 cp at 30 % solids
- Contain ‹ 10% by weight of materials with MW 500 or less
- Have no impact on flavor in odor when used in food applications
- Be suitable for commercial scale production
- Be sourced from sustainable raw materials Be derived from non-GMO, non allergenic (no peanut, dairy, etc.) sources
- Behave as an emulsifying agent.
Materials that have been produced at pilot scale are of greatest interest. However, materials that have been produced at the kilogram scale are also of interest if there is a clear path towards commercial scalability.
They are interested in licensing, product acquisition, joint development, supplier agreement.
Biopolymers are commonly used raw materials in both food and non-food applications. In food products, they may function as fillers or bulking agents, texture or viscosity modifiers, energy sources and as stabilizers. In more specialized applications, biopolymers can be used carriers and encapsulants for flavor and fragrance materials.
Biopolymers may be derived from botanical, marine, microbial, and animal sources. Common and commercially available examples include starches from corn or tapioca, carrageenan from seaweek, xanthan gum from bacteria, and gelatin from animal skin or bones. Physical, chemical, and enzymatic methods may be used to further modify polymers, yielding materials with enhanced properties.
Most biopolymers have high molecular weights that typically produce high viscosity through physical, chemical, or enzymatic means way result in the loss of desirable properties and/or in the formation of low molecular weight oligomers that may adversely affect the properties of the finished product.
The company is interested in identifying novel eligible biopolymers that create highly concentrated aqueous dispersions with low viscosity. These materials will preferably also possess desirable functional properties, such as the ability to serve as an emulsifying agent, to form films or minimize stickiness. Preferred biopolymers will already be produced at pilot scale of better and will have roughly the same cost-in-use as market products.
Anticipated approaches include, but are not limited to, the following:
- Enzymatic, chemical, and/or physical modification of naturally occurring or commercially available polymers or other feedstock
- Isolation or synthesis of novel biopolymers via fermentation or other biochemical methods.
The following approaches are not of interest:
- Approaches that result in unacceptable levels of hazardous chemicals as defined by FDA 21 CFR Part 184
- Early stage approaches or materials that cannot be scaled to industrial levels.
Technical Specifications / Specific technical requirements:
The successful biopolymer will:
- Be approved for use in food products or have potential to be approved for such use
- Disperse readily in water
- Produce low viscosity aqueous dispersions: ‹ 40 cp at 30 % solids
- Contain ‹ 10% by weight of materials with MW 500 or less
- Have no impact on flavor in odor when used in food applications
- Be suitable for commercial scale production
- Be sourced from sustainable raw materials Be derived from non-GMO, non allergenic (no peanut, dairy, etc.) sources
- Behave as an emulsifying agent.
Materials that have been produced at pilot scale are of greatest interest. However, materials that have been produced at the kilogram scale are also of interest if there is a clear path towards commercial scalability.
Požadavky na partnera:
Requested Cooperation: License Agreement, Joint further development
Responses from companies (large or small, startups, etc.), hospital or academic researchers, contract research institutes, pharmacologists, nutritionists, medicinal chemists, drug formulators, biochemists, physiologists, alternative or traditional medicine providers, etc., from around the world are all welcome.
ANTICIPATED PROJECT PHASES OR PROJECT PLAN
Phase 1 proof of concept: demonstration of physical properties meeting specifications and ability to produce biopolymer consistently at pilot scale.
Phase 2 product development: develop product formulations, assess shelf stability, identify benefits and/or minimize possible negative side effects. A demonstration of scalability of biopolymer and assessment of regulatory status are required.
Phase 3 commercial development: optimization of product formulations; technology transfer to manufacturing.
Criteria for moving from phase 1 to phase 2
Successful evaluation of the biopolymer in client application and ability to produce at the kilogram scale.
Note that this profile requires a convincing solution proposal. Please contact your local EEN to get the Response template and find more information on the specific process here: http://www.us-eu-match.com/index.cfm?action=processFlow
Responses from companies (large or small, startups, etc.), hospital or academic researchers, contract research institutes, pharmacologists, nutritionists, medicinal chemists, drug formulators, biochemists, physiologists, alternative or traditional medicine providers, etc., from around the world are all welcome.
ANTICIPATED PROJECT PHASES OR PROJECT PLAN
Phase 1 proof of concept: demonstration of physical properties meeting specifications and ability to produce biopolymer consistently at pilot scale.
Phase 2 product development: develop product formulations, assess shelf stability, identify benefits and/or minimize possible negative side effects. A demonstration of scalability of biopolymer and assessment of regulatory status are required.
Phase 3 commercial development: optimization of product formulations; technology transfer to manufacturing.
Criteria for moving from phase 1 to phase 2
Successful evaluation of the biopolymer in client application and ability to produce at the kilogram scale.
Note that this profile requires a convincing solution proposal. Please contact your local EEN to get the Response template and find more information on the specific process here: http://www.us-eu-match.com/index.cfm?action=processFlow
Obchodní firma/fyzická osoba:
Technologické inovační centrum s.r.o.
Kontaktní osoba:
Lenka Kostelníková
Email:
Telefon:
+420 739 570 792
